A Validation of a Post-Hypomethylating Agent Failure (HMAF) Prognostic Model in MDS Patients Treated with Rigosertib Versus Best Supportive Care (BSC)

Journal article

Peer reviewed

A. Nazha, M. Sekeres, R. Komrokji, D. Steensma, H. Kantarjian, G. Roboz, P. Fenaux, T. Prebet, N. Azarnia, P. Zbyszewski, …

Leukemia research, Vol.55, pp.S147-S148

2017-04

Metrics

1 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: A Validation of a Post-Hypomethylating Agent Failure (HMAF) Prognostic Model in MDS Patients Treated with Rigosertib Versus Best Supportive Care (BSC)
Creators: A. Nazha
M. Sekeres
R. Komrokji
D. Steensma
H. Kantarjian
G. Roboz
P. Fenaux
T. Prebet
N. Azarnia
P. Zbyszewski
S. Fruchtman
V. Santini
L. Silverman
U. Platzbecker
G. Garcia-Manero
Publication Details: Leukemia research, Vol.55, pp.S147-S148
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031757349102976